Health TrialsbyHealthPanel

Idiopathic Parkinson's Disease

2

Review clinical trials related to Idiopathic Parkinson's Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease

This is a randomized, placebo-controlled, double-blind, dose-finding phase 1b study with the purpose to assess the safety, immunogenicity and pharmacodynamics of TRB-001 in early idiopathic Parkinson's Disease patients.

Participants needed: 36
Trial details
Phase: Phase 1Age: 40-75Biological sex: AllType: InterventionalSponsor: Tridem Bioscience FlexCoUpdated: Sep 24, 2026Locations: 1
Eligibility criteria

Female or male patients aged 40-75 years old. Refer to section 5.3 for reproduct... [+5]

Known or suspected allergy, or history of anaphylaxis, to vaccines or their exci... [+14]

Read more
Status: Not yet recruiting

Evaluating Safety, Tolerability, and Efficacy of Autologous MitoCell Transplantation in Subjects With Idiopathic Parkinson's Disease

Primary Objective: To assess the safety profile of autologous MitoCell administered to subjects with idiopathic Parkinson's disease (PD) Secondary Objective: To explore the efficacy and safety of MitoCell given as the recommended dose by stereotactic intrastriatal implantation

Participants needed: 9
Trial details
Phase: Phase 1Age: 45-70Biological sex: AllType: InterventionalSponsor: Taiwan Mitochondrion Applied Technology Co., Ltd.Updated: Nov 21, 2024
Eligibility criteria

Provision of signed and dated informed consent form [+9]

Atypical or secondary Parkinsonism [+34]

Read more